Word on the street is she resigned sometime around March -in favour of a new role - and finishes up at OncoSil in next few weeks-ish. That's all I got.
Not a good look losing 2 x VP Regulatory & 1 x VP Clinical Research in approx 6 months, especially during critical FDA and NB discussions. Pretty telling sign of approval chances being zero.
OSL Price at posting:
15.0¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)